Every time you swallow a tablet, you trust that it will work exactly as intended. You expect the medication to release its ...
Morning Overview on MSN
A widely prescribed water pill was recalled because the tablets may not dissolve
Chlorthalidone 25 mg tablets, a long-established diuretic taken for high blood pressure and fluid retention, have been recalled because they failed dissolution testing. A tablet that does not break ...
Thousands of bottles of a popular blood pressure medication are being recalled over concerns about effectiveness. Inventia Healthcare Limited is voluntarily recalling 13,567 bottles of Chlorthalidone ...
FDA Chlorthalidone dissolution testing recall: Over 25,000 bottles of blood pressure medication have been recalled for improper dissolution. Reports claim that India based Inventia Healthcare Limited ...
Latvian researchers have built a dissolution-permeation system that couples a standard pharmacopoeial dissolution apparatus to an Ussing chamber, enabling simultaneous measurement of drug release and ...
NEWARK, Del, Dec. 13, 2022 (GLOBE NEWSWIRE) -- During the forecast period 2023-2033, the pharmaceutical dissolution testing services market is expected to grow at a value of 8.3% CAGR, according to ...
Women on CagriSema lost 25% of their body weight in a post hoc trial analysis, while 79.6% of users had digestive side effects. The drug is not approved. In 1948, researchers stressed a nursing mother ...
WASHINGTON — The FDA has classified a second nationwide recall of chlorthalidone blood pressure tablets from the same manufacturer as a Class II recall after more than 13,000 bottles failed ...
The US Food and Drug Administration (FDA) on Wednesday released final guidance for sponsors on when a standard release test and criteria may be used in lieu of extensive method development and ...
The company initiated the voluntary recall on September 3, 2026, after the tablets failed to meet dissolution specifications. The FDA classified the recall on September 17, meaning patients should ...
Researchers developed ebastine-loaded Solusome nanovesicle oral lyophilisates that disintegrate in seconds and raised the drug's oral bioavailability 3.21-fold in rats.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results